Evolus (NASDAQ: EOLS) has announced the appointment of Tatjana Mitchell as chief financial officer (CFO), effective today. Ms. Mitchell brings more than 20 years of strategic and operational finance leadership across...
electroCore (NASDAQ: ECOR) has announced the election of Thomas J. Errico, MD, as chairman of the board and the departure of Peter Cuneo from its board of directors (BOD). According to electroCore, Mr. Cuneo will...
Adagene (NASDAQ: ADAG) has announced the appointment of immuno-oncology pioneer, Axel Hoos, MD, PhD, as executive advisor. Most recently, Dr. Hoos served as CEO of Scorpion Therapeutics, which was acquired by Eli Lilly...
CASI Pharmaceuticals (NASDAQ: CASI) has announced the appointment of Barbara Krebs-Pohl, PhD, as an independent director to its board of directors (BOD). Dr. Krebs-Pohl brings more than 27 years of leadership experience...
Perimeter Medical Imaging AI (TSX-V: PINK; OTCQX: PYNKF) has announced the appointment of Ted James, MD, MHCM, FACS, to the newly created position of chief medical officer (CMO). In this fractional role, Dr...
QT Imaging (OTCQB: QTIH) has announced the appointment of Jay Jennings as its new chief financial officer (CFO). Mr. Jennings’ overall responsibility will include operational finance, financial reporting, budgeting and...
Aligos Therapeutics (NASDAQ: ALGS) has announced the appointment of Ramón Polo, PharmD, PhD, MBA as senior vice president, head of global regulatory affairs, effective immediately. Dr. Polo’s extensive background...
Alto Neuroscience (NYSE: ANRO) has announced the appointment of industry veteran Raymond Sanchez, MD, to its board of directors (BOD), effective August 12, 2025. Dr. Sanchez brings extensive experience in medicine and...
Senti Bio (NASDAQ: SNTI) has announced the appointment of entrepreneurial leader and investor Bryan Baum to its board of directors (BOD). Mr. Baum is the co-founder and managing partner of K5 Global. His portfolio...
Iovance Biotherapeutics (NASDAQ: IOVA) has announced the appointment of Corleen Roche as chief financial officer (CFO), effective August 6, 2025. Ms. Roche brings three decades of biotech and life sciences industry...